World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
44
Citations
9506
World Ranking
19232
National Ranking
7859

Yupo Ma publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Yupo Ma sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 129 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Yupo Ma D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Yupo Ma sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 44 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Yupo Ma is a researcher affiliated with Stony Brook University in the United States. Their primary fields of study are Medicine and Immunology and Microbiology, with significant contributions to subfields including Immunology, Oncology, Genetics, Physiology, and Molecular Biology.

The research focus of Yupo Ma covers multiple topics, notably:

  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Virus-based gene therapy research
  • T-cell and B-cell Immunology
  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Systemic Lupus Erythematosus Research

Yupo Ma has contributed to various recent publications, including:

  • "Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer" (2021, Cancer Letters)
  • "BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial" (2024, Annals of the Rheumatic Diseases)
  • "Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells" (2021, Stem Cell Reviews and Reports)
  • "Treatment of Systemic Lupus Erythematosus using BCMA-CD19 Compound CAR" (2021, Stem Cell Reviews and Reports)
  • "Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells" (2021, Pharmacological Research)

The most frequent publication venues where Yupo Ma's work has appeared include:

  • Stem Cell Reviews and Reports
  • Annals of the Rheumatic Diseases
  • Frontiers in Immunology
  • Cancer Letters
  • Pharmacological Research

Frequent collaborators in Yupo Ma's research network are:

  • M. Wada
  • Kevin G. Pinz
  • Wenli Zhang
  • Jia Feng
  • Hongyu Zhang

Best Publications

  • Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1.

    Jinqiu Zhang;Wai-Leong Tam;Wai-Leong Tam;Guo Qing Tong;Qiang Wu

  • Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties

    Elaine Lai-Han Leung;Ronald R. Fiscus;Ronald R. Fiscus;James W. Tung;Vicky Pui-Chi Tin

  • Phenotypic correction of murine hemophilia A using an iPS cell-based therapy

    Dan Xu;Zaida Alipio;Louis M. Fink;Dorothy M. Adcock

  • SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice

    Yupo Ma;Wei Cui;Jianchang Yang;Jun Qu

  • Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.

    Hesham M Amin;Timothy J McDonnell;Yupo Ma;Quan Lin

  • Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells

    Jianchang Yang;Li Chai;Taylor C. Fowles;Zaida Alipio

  • A Novel SALL4/OCT4 Transcriptional Feedback Network for Pluripotency of Embryonic Stem Cells

    Jianchang Yang;Chong Gao;Li Chai;Yupo Ma

  • Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells.

    Jianchang Yang;Li Chai;Fang Liu;Louis M. Fink

  • Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor

    K. H. Chen;M. Wada;K. G. Pinz;H. Liu

  • Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts.

    Hui Gai;Elaine Lai-Han Leung;Peter D. Costantino;Jerell R. Aguila

  • SALL4 is a key regulator of survival and apoptosis in human leukemic cells

    Jianchang Yang;Li Chai;Chong Gao;Taylor C. Fowles

  • Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma.

    Hesham M Amin;L Jeffrey Medeiros;Yupo Ma;Marianna Feretzaki

  • Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors

    Oscar B. Goodman;Louis M. Fink;James T. Symanowski;Bryan Wong

  • Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer.

    Ze-Bo Jiang;Wen-Jun Wang;Cong Xu;Ya-Jia Xie

  • In Vivo Cardiac Cellular Reprogramming Efficacy Is Enhanced by Angiogenic Preconditioning of the Infarcted Myocardium With Vascular Endothelial Growth Factor

    Megumi Mathison;Robert P. Gersch;Ahmed Nasser;Sarit Lilo

  • BRCA1 is a negative modulator of the PRC2 complex

    Lan Wang;Xianzhuo Zeng;Shuai Chen;Liya Ding

  • CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS OF USE THEREOF

    Yupo Ma;Kevin Pinz;Xun Jiang;Masayuki Wada

  • SALL4 is a robust stimulator for the expansion of hematopoietic stem cells

    Jerell R. Aguila;Wenbin Liao;Jianchang Yang;Cecilia Avila

  • First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial

    Fang Liu;Yuanzhen Cao;Kevin Pinz;Yu Ma

  • Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies.

    Kevin H. Chen;Masayuki Wada;Amelia E. Firor;Kevin G. Pinz

Frequent Co-Authors

Raymond Lai
Raymond Lai University of Alberta
Yu Zhang
Yu Zhang Peking University
Xinxin Ding
Xinxin Ding University of Arizona
David C. Ward
David C. Ward Nevada Cancer Research Foundation
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Leslie E. Silberstein
Leslie E. Silberstein Boston Children's Hospital
Thomas L. Benjamin
Thomas L. Benjamin Harvard University
Bing Lim
Bing Lim Thymmune Therapeutics
Huck-Hui Ng
Huck-Hui Ng Genome Institute of Singapore
Haifa Shen
Haifa Shen Houston Methodist

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens doors to a wide range of interdisciplinary career options. In the USA, many professionals choose to further their studies online, helping them balance work and education.

For those interested in the pharmaceutical sector, pharm d online programs offer a flexible route to earn an advanced degree and qualify for rewarding pharmacy careers. If applying biological principles to fitness and health sparks your interest, pursuing an exercise science and nutrition degree online could lead to opportunities in wellness, sports science, or allied health fields.

Those passionate about physical movement and rehabilitation may find kinesiology online programs to be a strong match, enabling careers in coaching, therapy, and research. For an accelerated path in mental health nursing, students can consider a 1 year pmhnp program online and step into much-needed psychiatric nurse practitioner roles.

Overall, online degrees offer flexibility and a direct pathway to specialized science and healthcare careers, making them ideal for students seeking advancement without sacrificing current commitments.

Best Scientists Citing Yupo Ma

Trending Scientists

Recently Published Articles